Teclapharm GmbH

Teclapharm GmbH Overview

Teclapharm GmbH is a pharmaceutical company based in Lüneburg, Hamburg. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).

Activities & Products

Pharmaceutical companies such as Teclapharm GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).

Location & Contact

Teclapharm GmbH can be reached at the following address: Heiligenthaler Str. 4, 21335 Lüneburg – Phone: 04131404100. For current information and enquiries, please contact the company directly.

More information: Pharmaunternehmen in Hamburg or all Pharmaunternehmen in Germany on Sanoliste.

Pharmazeutische Regulierung in Deutschland

Pharmaceutical companies such as Teclapharm GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.

Arzneimittelversorgung & Marktumfeld

With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Teclapharm GmbH, based in Lüneburg, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.

Pharmastandort Hamburg

Hamburg is a significant pharmaceutical location in Germany. Companies such as Teclapharm GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.